Skip to content
10-Q

Quarterly Report

ZIVO BIOSCIENCE, INC. ZIVO

0001654954-25-005748

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 10, 2025 3.81M sh
Shares Diluted Q1 2025 · Mar 31, 2025 3.75M sh
Shares Diluted Q1 2025 · Mar 31, 2024 2.75M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$1.43M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.7M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$1.62M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$514.9K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$2.27M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$2.21M
Current Liabilities Q1 2025 · Mar 31, 2025 $2.61M
Current Liabilities Q1 2025 · Dec 31, 2024 $2.04M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.95M
Total Liabilities Q1 2025 · Dec 31, 2024 $2.16M
Current Assets Q1 2025 · Mar 31, 2025 $1.02M
Current Assets Q1 2025 · Dec 31, 2024 $1.64M
Total Assets Q1 2025 · Mar 31, 2025 $1.33M
Total Assets Q1 2025 · Dec 31, 2024 $1.64M
Eps Diluted Q1 2025 · Mar 31, 2025 −$1.12
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.47
Sga Expense Q1 2025 · Mar 31, 2025 $1.44M
Sga Expense Q1 2025 · Mar 31, 2024 $975.57K
Rd Expense Q1 2025 · Mar 31, 2025 $2.77M
Rd Expense Q1 2025 · Mar 31, 2024 $312.77K
Net Income Q1 2025 · Mar 31, 2025 −$4.21M
Net Income Q1 2025 · Mar 31, 2024 −$1.28M
Operating Income Q1 2025 · Mar 31, 2025 −$4.21M
Operating Income Q1 2025 · Mar 31, 2024 −$1.28M
Gross Profit Q1 2025 · Mar 31, 2025 $0
Gross Profit Q1 2025 · Mar 31, 2024 $12.5K
Revenue Q1 2025 · Mar 31, 2025 $0
Revenue Q1 2025 · Mar 31, 2024 $35.72K